Albert P. Li, Binghe Wang - Drug-Drug Interactions in Pharmaceutical Development
Published: 2007-11-12 | ISBN: 0471794414 | PDF | 244 pages | 3 MB
Published: 2007-11-12 | ISBN: 0471794414 | PDF | 244 pages | 3 MB
Early evaluation of potential drug–drug interactions
Addressing the potential for adverse interactions among coadministered drugs before marketing a new drug can save time, money, and lives. In this reference, distinguished international experts comprehensively review the issues, relevant science, industrial practice, and regulatory agency positions on drug–drug interactions. Focusing on evaluation during the drug discovery process, Drug–Drug Interactions in Pharmaceutical Development:
Details the major scientific concepts and preclinical experimental approaches
Covers both clinical and nonclinical aspects
Discusses in vitro and in vivo methodologies
Covers genomic approaches
Addresses U.S., European, and Japanese regulations
Includes a chapter on herbal drug interactions
Compiling current information into one accessible resource, this is an excellent reference for industrial scientists and regulatory specialists in drug development as well as academic researchers and students in the fields of pharmacology, drug metabolism, and toxicology.
0 comments: